基于网络药理学及分子对接探讨槐花-地榆药对治疗溃疡性结肠炎的作用机制OA
Exploring the Mechanism of the Sophorae Flos-Sanguisorbae Radix Herb Pair in Treating Ulcerative Colitis Based on Network Pharmacology and Molecular Docking
目的 基于网络药理学及分子对接探讨槐花-地榆药对治疗溃疡性结肠炎(UC)的分子机制.方法 利用TCMSP、SwissTargetPrediction数据库筛选槐花-地榆药对的活性成分及成分靶点;采用GeneCards和OMIM数据库筛选UC疾病靶点,并取成分靶点与疾病靶点的交集确定槐花-地榆药对治疗UC的潜在治疗靶点.利用Cytoscape 3.9.0 软件与STRING数据库构建"药物-活性成分-靶点"网络及蛋白互作(PPI)网络,筛选出槐花-地榆药对治疗UC的关键成分及核心靶点.采用R4.1.1软件对潜在治疗靶点进行GO功能与KEGG通路富集分析,并结合桑基图构建"关键成分-核心靶点-通路"网络.采用AutoDock Vina验证关键成分与核心靶点的结合亲和力.结果 共筛选出槐花-地榆药对 13 个活性成分,84 个潜在治疗靶点;治疗UC的核心靶点有AKT1、IL-6、TNF、IL-1B、JUN等,关键成分有槲皮素、山柰酚、β-谷甾醇等.槐花-地榆药对治疗UC主要与调控氧化应激、脂多糖反应等生物过程有关;KEGG通路主要富集于Toll样受体通路、AGE-RAGE信号通路及TNF、TL-17通路等.桑基图结果呈现了槲皮素、山柰酚、β-谷甾醇等活性成分通过IL-6、TNF、IL-1B、JUN等靶点调控关键信号通路的完整网络.分子对接结果显示,关键成分槲皮素、山柰酚、β-谷甾醇与核心靶点(AKT1、IL-6、TNF、IL-1B、JUN)均具有高亲和力.结论 槐花-地榆药对可能通过槲皮素、β-谷甾醇等成分靶向AKT1、IL-6、TNF等靶点,协同调控Toll样受体通路及TNF、IL-17 炎症通路等,发挥治疗UC的作用.
Objective To investigate the molecular mechanism of the Sophorae Flos-Sanguisorbae Radix(SF-SR)herb pair in treating ulcerative colitis(UC)based on network pharmacology and molecular docking.Methods Active components and their corresponding targets of the SF-SR herb pair were screened using the TCMSP and SwissTargetPrediction databases.UC-related disease targets were collected from the GeneCards and OMIM databases.The potential therapeutic targets for SF-SR against UC were identified by intersecting the component targets with the disease targets.The"herb-active component-target"network and the protein-protein interaction(PPI)network were constructed using Cytoscape 3.9.0 software and the STRING database to screen the core components and core targets of the SF-SR herb pair for UC treatment.Gene Ontology(GO)functional enrichment analysis and Kyoto Encyclopedia of Genes and Genomes(KEGG)pathway enrichment analysis were performed on the potential therapeutic targets using R4.1.1 software,and a"key component-core target-pathway"network was constructed in conjunction with a Sankey diagram.The binding affinity between key components and key targets was validated using AutoDock Vina.Results A total of 13 active components and 84 potential therapeutic targets were screened.The core targets for SF-SR in treating UC included AKT1,IL-6,TNF,IL-1B,and JUN,while the core components included quercetin,kaempferol,and β-sitosterol.The therapeutic effects of the SF-SR herb pair were primarily associated with the regulation of biological processes such as oxidative stress response and lipopolysaccharide response.KEGG pathway analysis revealed significant enrichment in the Toll-like receptor signaling pathway,AGE-RAGE signaling pathway,TNF signaling pathway,and IL-17 signaling pathway,among others.The Sankey diagram presented a comprehensive network illustrating how active components like quercetin,kaempferol,and β-sitosterol regulate key signaling pathways through targets such as IL-6,TNF,IL-1B,and JUN.Molecular docking validation demonstrated that the key active components,quercetin,kaempferol,and β-sitosterol,exhibited high binding affinity with the core targets(AKT1,IL-6,TNF,IL-1B,JUN).Conclusion The Sophorae Flos-Sanguisorbae Radix herb pair may exert its therapeutic effect on ulcerative colitis by targeting molecules such as AKT1,IL-6,and TNF with components like quercetin and β-sitosterol,thereby coordinately regulating the Toll-like receptor signaling pathway as well as inflammatory pathways including TNF and IL-17 signaling.
马宇慧;孟佳磊
上海中医药大学附属第七人民医院,上海 200137上海中医药大学附属第七人民医院,上海 200137
医药卫生
槐花地榆药对网络药理学溃疡性结肠炎作用机制分子对接
Sophorae FlosSanguisorbae Radixherb pairnetwork pharmacologyulcerative colitismechanism of actionmolecular docking
《中药新药与临床药理》 2026 (1)
107-114,8
国家自然科学基金面上项目(82174189)浦东新区卫生健康委员会卫生计生科研项目(PW2022B-17)上海中医药大学附属第七人民医院人才培养计划项目(JY2024-09).
评论